Fennec Pharmaceuticals Inc

NASDAQ: FENC
Share price (5/13/24): $10.02
Market cap (5/13/24): $274 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 09/30/23 Q3

ended 06/30/23 Q2

ended 03/31/23 Q1

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Prospectus with selling stockholder info

Shelf registration

Prospectus supplement

Shelf registration

Shelf registration

Ownership Filter

News Filter

Conference Call & Webcast Detail

Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update

Fennec Pharmaceuticals and Norgine Enter Into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC